This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:co-infections [06.08.2011] – [Types] paulalbert | home:diseases:co-infections [07.03.2011] – paulalbert | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ~~NOTOC~~ | ||
====== Co-infections ====== | ====== Co-infections ====== | ||
Line 8: | Line 7: | ||
Because the Marshall Protocol activates the innate immune response, a system that is responsive to a range of microbes, there is a good chance the MP targets these infections. Patients on the MP experience an immunopathological reaction in eliminating any microbes including those labelled as co-infections. | Because the Marshall Protocol activates the innate immune response, a system that is responsive to a range of microbes, there is a good chance the MP targets these infections. Patients on the MP experience an immunopathological reaction in eliminating any microbes including those labelled as co-infections. | ||
- | ===== Types ===== | + | ===== Frequently cited types ===== |
* // | * // | ||
* // | * // | ||
- | * //Babesia// – //Babesia// is a protozoan parasite of the blood that causes a hemolytic disease known as Babesiosis. There are over 100 species of //Babesia// identified. | + | * //**Babesia**// – //Babesia// is a protozoan parasite of the blood that causes a hemolytic disease known as Babesiosis. There are over 100 species of //Babesia// identified. |
- | * //**Candida albicans**// – // | + | * **Cytomegalovirus** – A viral genus of the viral group known as Herpesviridae or herpesviruses. It is typically abbreviated as CMV. The species |
- | * **cytomegalovirus** | + | * // |
- | * // | + | |
* **Epstein-Barr virus** | * **Epstein-Barr virus** | ||
- | * // | + | * // |
+ | |||
+ | |||
+ | ==== Candida albicans ==== | ||
+ | |||
+ | < | ||
+ | |||
+ | //Candida albicans// is a fungus (a form of yeast) that plays a role in opportunistic oral and genital infections in humans. //C. albicans// biofilms readily form on the surface of implantable medical devices. Systemic fungal infections (fungemias) have emerged as important causes of morbidity and mortality in patients traditionally labelled as immunocompromised, | ||
+ | |||
+ | As the section devoted to antimicrobial peptides (AmPs) explains, the AmP cathelicidin is a component of the innate immune system, and is responsive to fungi.(({{pubmed> | ||
+ | |||
+ | Antifungal agents such as fluconazole (Diflucan) are sometimes prescribed to treat fungal infections. While some patients have reported feeling better after taking antifungal agents, antifungals interfere with immune function. | ||
+ | |||
+ | At least according to one study, patients are a poor judge of whether they have fungal infections. | ||
+ | |||
+ | < | ||
+ | Patient symptom scores were a poor predictor of yeast infections based on yeast culture results. ... Self-reported symptoms are not reliable for diagnosis. | ||
+ | |||
+ | //**Susan Hoffstetter** et al.// (({{pubmed> | ||
+ | |||
===== Term can be ambiguous ===== | ===== Term can be ambiguous ===== | ||